Corpus Intelligence IC Memo — BAYLOR EMERGENCY MEDICAL CENTER 2026-04-27 01:02 UTC
IC Memo — BAYLOR EMERGENCY MEDICAL CENTER
Investment Committee Memorandum | TX | 40 beds | Grade D | EBITDA uplift $3.7M
🛡️ Public data only — no PHI permitted on this instance.
INVESTMENT COMMITTEE MEMORANDUM  ·  CCN 670062

BAYLOR EMERGENCY MEDICAL CENTER

LOCATIONDENTON, TX·BEDS40·AS OFApril 27, 2026
D
INVESTABILITY
EBITDA BridgeData Room

1. Target Overview & Investment Thesis

BAYLOR EMERGENCY MEDICAL CENTER is a 40-bed community hospital in DENTON, TX with $49.6M in net patient revenue and a 17.2% operating margin. The hospital serves a payer mix of 22.9% Medicare, 0.0% Medicaid, and 77.1% commercial.

Thesis: Turnaround. Our ML models identify $3.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 17.2% to 24.6% (+736bps).

Net Revenue HCRIS$49.6M
Current EBITDA COMPUTED$8.6M
Operating Margin COMPUTED17.2%
Occupancy HCRIS5.8%
Revenue / Bed COMPUTED$1.2M
Net-to-Gross HCRIS27.3%
Distress Probability MLnan%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
286
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 17.2% places it above the state median. Among 286 size-comparable peers (20-80 beds), the median margin is -2.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (20-80), prioritizing same-state peers. 286 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BAYLOR EMERGENCY MEDICAL CENTE (Target)TX40$49.6M17.2%
WISE HEALTH SYSTEM - PARKWAYTX36$361.0M-15.5%
CHILDRENS MEDICAL CENTER OF PLTX72$336.7M20.9%
CORYELL MEMORIAL HOSPITALTX25$305.9M-1.5%
BAYLOR HEART AND VASCULAR HOSPTX53$255.0M30.0%
TEXAS ORTHOPEDIC HOSPITATX42$237.8M46.3%
LAKE GRANBURY MEDICAL CENTERTX53$181.6M38.5%
METHODIST HOSPITAL FOR SURGERYTX32$178.4M22.8%
BAYLOR MEDICAL CENTER AT FRISCTX68$161.1M10.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.0M+210bp18mo
Cost to Collect4.5%2.5%$993K+200bp12mo
Denial Rate Reduction12.0%6.5%$983K+198bp12mo
A/R Days Reduction5200.0%3800.0%$604K+122bp9mo
Clean Claim Rate88.0%96.0%$32K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.0M
Cost to Collect
$993K
Denial Rate Reduction
$983K
A/R Days Reduction
$604K
Clean Claim Rate
$32K
Total EBITDA Uplift$3.7M
Current EBITDA$8.6M
+ RCM Uplift+$3.7M
Pro Forma EBITDA$12.2M
Current Margin17.2%
Pro Forma Margin24.6%
WC Released (1x)$1.9M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$13.2M$93.0M7.06x47.9%
Base (11x exit)10.0x11.0x$13.2M$106.5M8.10x51.9%
Bull Case9.0x11.0x$11.8M$122.9M10.37x59.7%
Bull (12x exit)9.0x12.0x$11.8M$137.5M11.61x63.3%
Bear Case11.0x10.0x$14.5M$70.4M4.86x37.2%
Bear (11x exit)11.0x11.0x$14.5M$82.2M5.68x41.5%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 5.8%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 286 hospitals with 20-80 beds
  • Same-state prioritization (n=287)
  • Comp margins: P25=-23.7% / P50=-2.9% / P75=10.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 27, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.